Recent News

• 08.27.2025 - Seres Therapeutics to Participate in H.C. Wainwright 27th Annual Global Investment Conference
• 08.27.2025 - Seres Therapeutics to Participate in H.C. Wainwright 27th Annual Global Investment Conference
• 08.06.2025 - Q2 2025 Seres Therapeutics, Inc. Earnings Conference Call
• 08.06.2025 - Q2 2025 Seres Therapeutics, Inc. Earnings Conference Call
• 08.06.2025 - Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates
• 08.06.2025 - Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates
• 07.22.2025 - Seres Therapeutics to Announce Second Quarter 2025 Financial Results and Business Updates on August 6, 2025
• 07.22.2025 - Seres Therapeutics to Announce Second Quarter 2025 Financial Results and Business Updates on August 6, 2025
• 07.22.2025 - Seres Therapeutics Announces Leadership Transition
• 07.22.2025 - Seres Therapeutics Announces Leadership Transition

Recent Filings

• 08.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.06.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.06.2025 - 3 Initial statement of beneficial ownership of securities
• 08.06.2025 - 8-K Current report
• 08.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.06.2025 - EX-99.1 EX-99.1
• 08.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]